Benzinga | Oct 21, 2020 07:26AM EDT

BMO Capital Maintains Market Perform on Mirati Therapeutics, Raises Price Target to $176

BMO Capital maintains Mirati Therapeutics (NASDAQ:MRTX) with a Market Perform and raises the price target from $101 to $176.